Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
D014150:Antipsychotic Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000493:pharmacokinetics / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D003024:Clozapine / Q000493:pharmacokinetics / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003987:Dibenzothiazepines / Q000493:pharmacokinetics / Q000627:therapeutic use; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D015394:Molecular Structure; D000077152:Olanzapine; D010879:Piperazines / Q000493:pharmacokinetics / Q000627:therapeutic use; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000493:pharmacokinetics / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D013844:Thiazoles / Q000493:pharmacokinetics / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; C092292:ziprasidone; D003577:Cytochrome P-450 Enzyme System; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine